X

Health & Biotech

Immuron’s diarrhoea drug may help treat COVID-19; investors get excited

News that one of Immuron's (ASX:IMC) drug candidates could take on COVID-19 has got investors in a frenzy this morning. Immuron is…

CannPal’s doggie drug DermaCann tackles atopic dermatitis

Special Report: Animal health company CannPal has released data from a study into its hemp-derived cannabidiol (CBD) nutraceutical for skin…

Mandatory masks in Melbourne ignite these ASX small caps

Yesterday, the Victorian state government announced face masks would be mandatory in Melbourne from Wednesday at 11.59pm. People caught without…

Micro-X’s Rover gets the green light from the FDA

Portable x-ray manufacturer Micro-X (ASX:MX1) has announced its Rover product has been given FDA 510(k) clearance in just five weeks.…

MGC Pharma expands footprint with cannabis clinic acquisition

Bio-pharma company MGC Pharmaceuticals (ASX:MXC) has struck a $1.4m deal to acquire Australian clinic business Medicinal Cannabis Clinic and its…

Is Compass Cannabis your next ASX pot stock?

Special Report: Compass Cannabis is about to wrap up a successful equity raising via Birchal, and already has an eye…

Dr Boreham’s Crucible: Hydrix who?

That was your columnist’s first reaction on learning about the existence of the medical device development play - and we’re…

Respiri’s biggest deal yet gives it access to the world

Special Report: Respiri’s biggest ever sales agreement will yield significant sales in the first 12 months. Respiri (ASX:RSH), a company…

Incannex Healthcare’s cannabidiol treatment for respiratory disease looks promising, shares climb

Medicinal cannabis company Incannex Healthcare (ASX:IHL) says mice testing for its cannabidiol treatment has yielded some strong early results. The…

Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment…